Medpace Holdings Inc
MEDP: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$976.00 | Lddsqb | Klhmplm |
Medpace Benefits From Strong Clinical Trial Outsourcing Demand
Business Strategy and Outlook
Medpace is a global late-stage contract research organization, or CRO, that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. The company was founded over 30 years ago in Cincinnati. It is principally based in the US but also operates in Europe, Asia, South America, Africa, and Australia.